dPCR and qPCR Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Reagents & Consumables is the fastest growing segment, North America is the largest regional market

The Global dPCR and qPCR Products Market, valued at USD 8.24 Billion in 2024, is projected to experience a CAGR of 7.39% to reach USD 12.64 Billion by 2030. Digital Polymerase Chain Reaction (dPCR) and quantitative Polymerase Chain Reaction (qPCR) products are molecular diagnostic tools for precise nucleic acid detection and quantification. qPCR measures real-time amplification for relative or absolute quantification, while dPCR segments samples for absolute quantification, enhancing sensitivity for scarce targets. Market growth is driven by the rising global prevalence of infectious diseases and genetic disorders, alongside continuous technological advancements improving assay efficiency. Increased adoption in point-of-care diagnostics and personalized medicine also provides momentum.

Key Market Drivers

The increasing global prevalence of infectious diseases and genetic disorders constitutes a primary driver for the dPCR and qPCR products market. These advanced molecular diagnostic tools offer the sensitivity and specificity required for early detection and accurate quantification of pathogens and genetic mutations, which is crucial for effective disease management and public health initiatives. For instance, according to the WHO Global Tuberculosis Report 2024, published on November 1, 2024, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, a notable increase from 7.5 million in 2022, highlighting the persistent and growing burden of infectious diseases that necessitate precise diagnostic solutions. Similarly, the expanding understanding of genetic predispositions and heritable conditions fuels the demand for high-resolution genetic analysis enabled by dPCR and qPCR.

Key Market Challenges

High capital expenditure associated with digital Polymerase Chain Reaction (dPCR) instrumentation and specialized reagents presents a significant impediment to the growth of the Global dPCR and qPCR Products Market. The substantial upfront investment required for advanced dPCR systems, coupled with the ongoing costs of specific reagents, creates a financial barrier for potential adopters. This directly constrains market expansion by limiting the accessibility of these technologies to a wider range of laboratories, especially smaller research facilities, clinical diagnostic centers with restricted budgets, and institutions in emerging economies.

Key Market Trends

The integration of AI and cloud-based data analytics is transforming PCR workflows, enhancing data processing, interpretation, and accessibility. AI algorithms provide more precise analysis of complex assay results, improving diagnostic accuracy and accelerating turnaround times. Cloud platforms offer scalable solutions for data storage and collaborative research, vital for managing increasing genomic data volumes. QIAGEN, for instance, announced in April 2025 its upcoming QIAsymphony Connect system will integrate digital connectivity and be compatible with QIAsphere, its cloud-based platform for remote monitoring. This market evolution towards sophisticated computational infrastructure is further evidenced by the Association for Molecular Pathology in May 2025, releasing three interrelated Body of Knowledge papers defining essential bioinformatics competencies for clinical diagnostic laboratories.

Key Market Players Profiled:

• Abbott Laboratories, Inc.
• Agilent Technologies, Inc.
• Analytik Jena AG
• Becton Dickinson and Company
• Bio Molecular Systems Pty Ltd
• Biomeme Inc.
• Biomérieux S.A.
• Bioneer Corporation
• Bio-Rad Laboratories, Inc.
• Cole-Parmer Instrument Company LLC

Report Scope:

In this report, the Global dPCR and qPCR Products Market has been segmented into the following categories:

By Product:

By Application:

• Reagents & Consumables
• Instruments
• Software

By End User:

• Clinical Applications
• Forensic Applications

By Region:

• Hospitals & Diagnostic Centers
• Research Laboratories & Academic Institutes
• Clinical Research Organizations
• Others

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global dPCR and qPCR Products Market .

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.